{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T05:10:27Z","timestamp":1777612227396,"version":"3.51.4"},"reference-count":82,"publisher":"Oxford University Press (OUP)","issue":"24","license":[{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This article summarizes pharmacological and nonpharmacological therapies for cannabinoid hyperemesis syndrome (CHS) that may be utilized in the emergency department (ED).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>CHS is an increasingly common condition in the ED characterized by cyclic vomiting and abdominal pain in the setting of excessive consumption of cannabis or cannabinoid use. Symptoms are usually alleviated by hot baths or showers, but when they persist patients often present to the ED. Emergency medicine pharmacists should be able to recognize the common presentation of CHS and assist with treatment of these patients in the ED.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>There is a paucity of data regarding the most effective pharmacotherapy for CHS, but cessation of cannabis use is accepted as the quintessential cure. Common therapies for CHS include dopamine antagonists such as haloperidol and droperidol, conventional antiemetics such as ondansetron and metoclopramide, and topical capsaicin. Opioids and benzodiazepines should not be used as first-line therapy for CHS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ajhp\/zxaf125","type":"journal-article","created":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T07:34:19Z","timestamp":1748763259000},"page":"1340-1352","source":"Crossref","is-referenced-by-count":1,"title":["Managing cannabinoid hyperemesis syndrome in adult patients in the emergency department"],"prefix":"10.1093","volume":"82","author":[{"given":"Kimberly J","family":"Won","sequence":"first","affiliation":[{"name":"UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences , La Jolla, CA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Celmins","sequence":"additional","affiliation":[{"name":"UChicago Medicine , Chicago, IL ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"issue":"11","key":"2025120419221994100_zxaf125-B1","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1136\/gut.2003.036350","article-title":"Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse","volume":"53","author":"Allen","year":"2004","journal-title":"Gut"},{"issue":"7","key":"2025120419221994100_zxaf125-B2","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1007\/s11606-020-05800-7","article-title":"Medical reasons for marijuana use, forms of use, and patient perception of physician attitudes among the US population","volume":"35","author":"Azcarate","year":"2020","journal-title":"J Gen Intern Med"},{"issue":"6","key":"2025120419221994100_zxaf125-B3","doi-asserted-by":"publisher","first-page":"341","DOI":"10.4140\/TCP.n.2017.341","article-title":"Marijuana use in the elderly: implications and considerations","volume":"32","author":"Mahvan","year":"2017","journal-title":"Consult Pharm"},{"key":"2025120419221994100_zxaf125-B4"},{"issue":"10","key":"2025120419221994100_zxaf125-B5","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1089\/jpm.2018.0531","article-title":"Cannabis hyperemesis syndrome in palliative care: a case study and narrative review","volume":"22","author":"Howard","year":"2019","journal-title":"J Palliat Med"},{"key":"2025120419221994100_zxaf125-B6","article-title":"Most Americans now live in a legal marijuana state\u2014and most have at least one dispensary in their county","author":"Chapekis"},{"issue":"11-12","key":"2025120419221994100_zxaf125-B7","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1111\/apt.17265","article-title":"Cannabinoid hyperemesis syndrome in North America: evaluation of health burden and treatment prevalence","volume":"56","author":"Andrews","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"2025120419221994100_zxaf125-B8"},{"key":"2025120419221994100_zxaf125-B9"},{"key":"2025120419221994100_zxaf125-B10","author":"Substance Abuse and Mental Health Services Administration"},{"issue":"8","key":"2025120419221994100_zxaf125-B11","doi-asserted-by":"publisher","first-page":"531","DOI":"10.7326\/M18-2809","article-title":"Acute illness associated with cannabis use, by route of exposure: an observational study","volume":"170","author":"Monte","year":"2019","journal-title":"Ann Intern Med"},{"issue":"1","key":"2025120419221994100_zxaf125-B12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1159\/000520417","article-title":"A systematic review on cannabis hyperemesis syndrome and its management options","volume":"31","author":"Senderovich","year":"2022","journal-title":"Med Princ Pract"},{"issue":"3","key":"2025120419221994100_zxaf125-B13","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1089\/can.2021.0046","article-title":"Cannabinoid hyperemesis syndrome survey and genomic investigation","volume":"7","author":"Russo","year":"2022","journal-title":"Cannabis Cannabinoid Res"},{"issue":"1","key":"2025120419221994100_zxaf125-B14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s13181-016-0595-z","article-title":"Cannabinoid hyperemesis syndrome: diagnosis, pathophysiology, and treatment\u2014a systematic review","volume":"13","author":"Sorensen","year":"2017","journal-title":"J Med Toxicol"},{"issue":"5","key":"2025120419221994100_zxaf125-B15","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1053\/j.gastro.2024.01.040","article-title":"AGA clinical practice update on diagnosis and management of cannabinoid hyperemesis syndrome: commentary","volume":"166","author":"Rubio-Tapia","year":"2024","journal-title":"Gastroenterology"},{"issue":"6","key":"2025120419221994100_zxaf125-B16","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/phar.1931","article-title":"Pharmacologic treatment of cannabinoid hyperemesis syndrome: a systematic review","volume":"37","author":"Richards","year":"2017","journal-title":"Pharmacotherapy"},{"issue":"6","key":"2025120419221994100_zxaf125-B17","doi-asserted-by":"publisher","first-page":"571","DOI":"10.20524\/aog.2020.0528","article-title":"Cannabis hyperemesis syndrome: an update on the pathophysiology and management","volume":"33","author":"Perisetti","year":"2020","journal-title":"Ann Gastroenterol"},{"issue":"12","key":"2025120419221994100_zxaf125-B18","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1111\/nmo.12931","article-title":"The gastrointestinal tract\u2014a central organ of cannabinoid signaling in health and disease","volume":"28","author":"Hasenoehrl","year":"2016","journal-title":"Neurogastroenterol Motil"},{"issue":"3","key":"2025120419221994100_zxaf125-B19","doi-asserted-by":"publisher","first-page":"e14911","DOI":"10.1111\/nmo.14911","article-title":"Endocannabinoid signaling in stress, nausea, and vomiting","volume":"37","author":"DeVuono","year":"2025","journal-title":"Neurogastroenterol Motil"},{"issue":"4","key":"2025120419221994100_zxaf125-B20","doi-asserted-by":"publisher","first-page":"G655","DOI":"10.1152\/ajpgi.00294.2015","article-title":"Endocannabinoids in the gastrointestinal tract","volume":"311","author":"Lee","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"6","key":"2025120419221994100_zxaf125-B21","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/ajo.13714","article-title":"Cannabinoid hyperemesis syndrome in pregnancy: challenges and opportunities","volume":"63","author":"Kirby","year":"2023","journal-title":"Aust NZ J Obstet Gynecol"},{"issue":"3","key":"2025120419221994100_zxaf125-B22","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.jemermed.2017.12.010","article-title":"Cannabinoid hyperemesis syndrome: pathophysiology and treatment in the emergency department","volume":"54","author":"Richards","year":"2018","journal-title":"J Emerg Med"},{"issue":"4","key":"2025120419221994100_zxaf125-B23","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1179\/2295333714Y.0000000116","article-title":"A non-classical cannabinoid syndrome","volume":"70","author":"Muschart","year":"2015","journal-title":"Acta Clin Belg"},{"key":"2025120419221994100_zxaf125-B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2025.01.008","article-title":"Cannabinoid hyperemesis syndrome is associated with high disease burden: an internet-based survey","author":"Meltzer","journal-title":"Ann Emerg Med."},{"key":"2025120419221994100_zxaf125-B25"},{"issue":"3","key":"2025120419221994100_zxaf125-B26","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1053\/j.gastro.2021.11.019","article-title":"Clinical diagnostic criteria for disorders of gut-brain interaction","volume":"162","author":"Drossman","year":"2022","journal-title":"Gastroenterology"},{"key":"2025120419221994100_zxaf125-B27","doi-asserted-by":"publisher","first-page":"1307345","DOI":"10.1155\/2019\/1307345","article-title":"Emergency department and radiological cost of delayed diagnosis of cannabinoid hyperemesis","volume":"2019","author":"Zimmer","year":"2019","journal-title":"J Addict"},{"issue":"5","key":"2025120419221994100_zxaf125-B28","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/acem.14911","article-title":"Guidelines for reasonable and appropriate care in the emergency department (GRACE-4). Alcohol use disorder and cannabinoid hyperemesis syndrome management in the emergency department","volume":"31","author":"Borgundvaag","year":"2024","journal-title":"Acad Emerg Med"},{"issue":"8","key":"2025120419221994100_zxaf125-B29","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1136\/jim-2020-001564","article-title":"Cannabinoid hyperemesis syndrome: definition, pathophysiology, clinical spectrum, insights into acute and long-term management","volume":"68","author":"Gajendran","year":"2020","journal-title":"J Investig Med"},{"issue":"5","key":"2025120419221994100_zxaf125-B30","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1177\/0897190020934289","article-title":"Management of cannabinoid hyperemesis syndrome: focus on capsaicin","volume":"34","author":"Stumpf","year":"2021","journal-title":"J Pharm Pract"},{"issue":"9","key":"2025120419221994100_zxaf125-B31","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1080\/15563650.2018.1564324","article-title":"The utility of droperidol in the treatment of cannabinoid hyperemesis syndrome","volume":"57","author":"Lee","year":"2019","journal-title":"Clin Toxicol"},{"key":"2025120419221994100_zxaf125-B32","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2147\/OAEM.S473627","article-title":"Droperidol plus diphenhydramine for symptom improvement in suspected cannabinoid hyperemesis syndrome: a prospective cohort study","volume":"16","author":"Chopra","year":"2024","journal-title":"Open Access Emerg Med"},{"issue":"5","key":"2025120419221994100_zxaf125-B33","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/acem.14770","article-title":"SAEM GRACE: dopamine antagonists and topical capsaicin for cannabis hyperemesis syndrome in the emergency department: a systematic review of direct evidence","volume":"31","author":"Sabbineni","year":"2024","journal-title":"Acad Emerg Med"},{"issue":"6","key":"2025120419221994100_zxaf125-B34","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.annemergmed.2020.08.021","article-title":"Intravenous haloperidol versus ondansetron for cannabinoid hyperemesis syndrome (HaVOC): a randomized controlled trial","volume":"77","author":"Ruberto","year":"2021","journal-title":"Ann Emerg Med"},{"key":"2025120419221994100_zxaf125-B35"},{"key":"2025120419221994100_zxaf125-B36"},{"key":"2025120419221994100_zxaf125-B37","doi-asserted-by":"publisher","first-page":"3614053","DOI":"10.1155\/2016\/3614053","article-title":"Successful treatment of suspected cannabinoid hyperemesis syndrome using haloperidol in the outpatient setting","volume":"2016","author":"Jones","year":"2016","journal-title":"Case Rep Psychiatry"},{"issue":"4","key":"2025120419221994100_zxaf125-B38","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/PRA.0000000000000564","article-title":"Treatment of cannabinoid hyperemesis with olanzapine: a case series","volume":"27","author":"Hsu","year":"2021","journal-title":"J Psychiatr Pract"},{"issue":"6","key":"2025120419221994100_zxaf125-B39","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1001\/jamaoncol.2020.1052","article-title":"Olanzapine for the treatment of advanced cancer-related chronic nausea and\/or vomiting: a randomized pilot trial","volume":"6","author":"Navari","year":"2020","journal-title":"JAMA Oncol"},{"issue":"9","key":"2025120419221994100_zxaf125-B40","doi-asserted-by":"publisher","first-page":"CD012555","DOI":"10.1002\/14651858.CD012555.pub2","article-title":"Olanzapine for the prevention and treatment of cancer-related nausea and vomiting in adults","volume":"9","author":"Sutherland","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"2025120419221994100_zxaf125-B41"},{"issue":"7","key":"2025120419221994100_zxaf125-B42","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.ajem.2019.09.007","article-title":"Effectiveness and safety of droperidol in a United States emergency department","volume":"38","author":"Gaw","year":"2020","journal-title":"Am J Emerg Med"},{"issue":"22","key":"2025120419221994100_zxaf125-B43","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1093\/ajhp\/zxaa271","article-title":"Reintegrating droperidol into emergency medicine practice","volume":"77","author":"Mattson","year":"2020","journal-title":"Am J Health-Syst Pharm"},{"key":"2025120419221994100_zxaf125-B44","doi-asserted-by":"publisher","first-page":"285.e7","DOI":"10.1016\/j.ajem.2021.09.048","article-title":"QTc prolongation in cannabis hyperemesis syndrome patients exposed to antiemetics: a retrospective chart review","volume":"53","author":"Carrillo","year":"2022","journal-title":"Am J Emerg Med"},{"key":"2025120419221994100_zxaf125-B45"},{"issue":"11","key":"2025120419221994100_zxaf125-B46","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1111\/acem.14062","article-title":"A pilot trial of topical capsaicin cream for the treatment of cannabinoid hyperemesis syndrome","volume":"27","author":"Dean","year":"2020","journal-title":"Acad Emerg Med"},{"issue":"6","key":"2025120419221994100_zxaf125-B47","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1080\/15563650.2019.1660783","article-title":"Efficacy and safety of topical capsaicin for cannabinoid hyperemesis syndrome in the emergency department","volume":"58","author":"Wagner","year":"2020","journal-title":"Clin Toxicol"},{"key":"2025120419221994100_zxaf125-B48","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ajem.2021.06.049","article-title":"Efficacy of topical capsaicin for cannabinoid hyperemesis syndrome in a pediatric and adult emergency department","volume":"49","author":"Kum","year":"2021","journal-title":"Am J Emerg Med"},{"issue":"2","key":"2025120419221994100_zxaf125-B49","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1177\/10600280211018516","article-title":"Use of capsaicin cream in cannabinoid hyperemesis syndrome in patients presenting to the emergency department","volume":"56","author":"Lee","year":"2022","journal-title":"Ann Pharmacol"},{"key":"2025120419221994100_zxaf125-B50","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ajem.2021.01.073","article-title":"Efficacy of topical capsaicin for the treatment of cannabinoid hyperemesis syndrome: a retrospective cohort study","volume":"43","author":"Yusuf","year":"2021","journal-title":"Am J Emerg Med"},{"key":"2025120419221994100_zxaf125-B51","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ajem.2021.01.004","article-title":"Topical capsaicin for the treatment of cannabinoid hyperemesis syndrome, a systematic review and meta-analysis","volume":"43","author":"Pourmand","year":"2021","journal-title":"Am J Emerg Med"},{"key":"2025120419221994100_zxaf125-B52"},{"key":"2025120419221994100_zxaf125-B53","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1177\/1753495X241307415","article-title":"Cannabinoid hyperemesis syndrome in pregnancy: a case series and review","volume":"24","author":"Hanley","journal-title":"Obstet Med. Published online December"},{"issue":"1","key":"2025120419221994100_zxaf125-B54","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1097\/AOG.0000000000002456","article-title":"ACOG practice bulletin no. 189: nausea and vomiting of pregnancy","volume":"131","author":"Committee on Practice Bulletins\u2013Obstetrics","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"6","key":"2025120419221994100_zxaf125-B55","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1097\/AOG.0000000000005202","article-title":"ACOG practice bulletin no. 92: treatment and management of mental health conditions during pregnancy","volume":"141","author":"Committee on Practice Bulletins\u2013Obstetrics","year":"2023","journal-title":"Obstet Gynecol"},{"issue":"9","key":"2025120419221994100_zxaf125-B56","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1089\/jwh.2023.0341","article-title":"Polysubstance use in pregnancy: surveillance, interventions and next steps","volume":"32","author":"Park","year":"2023","journal-title":"J Womens Health"},{"issue":"2","key":"2025120419221994100_zxaf125-B57","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3978\/j.issn.2224-5820.2012.07.07","article-title":"5-HT3 receptor antagonists for the treatment of nausea\/vomiting","volume":"1","author":"Smith","year":"2012","journal-title":"Ann Palliat Med"},{"issue":"1","key":"2025120419221994100_zxaf125-B58","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/fcp.12580","article-title":"Cannabinoid hyperemesis syndrome in two French emergency departments: a prospective cohort","volume":"35","author":"Weiss","year":"2021","journal-title":"Fundam Clin Pharmacol"},{"issue":"2","key":"2025120419221994100_zxaf125-B59","doi-asserted-by":"publisher","first-page":"e34552","DOI":"10.7759\/cureus.34552","article-title":"Recurrent severe burns due to cannabinoid hyperemesis syndrome","volume":"15","author":"Osagie","year":"2023","journal-title":"Cureus"},{"issue":"1","key":"2025120419221994100_zxaf125-B60","doi-asserted-by":"publisher","first-page":"e227836","DOI":"10.1136\/bcr-2018-227836","article-title":"Erythema ab igne as a complication of cannabinoid hyperemesis syndrome","volume":"12","author":"Sahu","year":"2019","journal-title":"BMJ Case Rep"},{"issue":"6","key":"2025120419221994100_zxaf125-B61","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.mayocp.2022.12.017","article-title":"Erythema ab igne associated with cannabinoid hyperemesis syndrome","volume":"98","author":"Green","year":"2023","journal-title":"Mayo Clin Proc"},{"issue":"11","key":"2025120419221994100_zxaf125-B62","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1007\/s11606-013-2446-9","article-title":"Some like it hot: erythema ab igne due to cannabinoid hyperemesis","volume":"28","author":"Kraemer","year":"2013","journal-title":"J Gen Intern Med"},{"issue":"12","key":"2025120419221994100_zxaf125-B63","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1007\/s11606-017-4111-1","article-title":"Running out of options: rhabdomyolysis associated with cannabis hyperemesis syndrome","volume":"32","author":"Trappey","year":"2017","journal-title":"J Gen Intern Med"},{"issue":"31","key":"2025120419221994100_zxaf125-B64","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.15585\/mmwr.mm6931a1","article-title":"Alcohol use and co-use of other substances among pregnant females aged 12\u201344 years: United States, 2015\u20132018","volume":"69","author":"England","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"2025120419221994100_zxaf125-B65","doi-asserted-by":"crossref","first-page":"e009986","DOI":"10.1136\/bmjopen-2015-009986","article-title":"Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis","volume":"6","author":"Gunn","year":"2016","journal-title":"BMJ Open"},{"issue":"7","key":"2025120419221994100_zxaf125-B66","doi-asserted-by":"publisher","first-page":"492","DOI":"10.7326\/M18-1141","article-title":"Data are needed on the potential adverse effects of marijuana use in pregnancy","volume":"167","author":"Goler","year":"2018","journal-title":"Ann Intern Med"},{"issue":"3","key":"2025120419221994100_zxaf125-B67","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/s0892-0362(00)00066-0","article-title":"Effects of prenatal marijuana exposure on child behavior problems at age 10","volume":"22","author":"Goldschmidt","year":"2000","journal-title":"Neurotoxicol Teratol"},{"issue":"2","key":"2025120419221994100_zxaf125-B68","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1177\/1715163519893395","article-title":"Cannabis use in pregnancy and breastfeeding: the pharmacist\u2019s role","volume":"153","author":"Davis","year":"2020","journal-title":"Can Pharm J"},{"issue":"6","key":"2025120419221994100_zxaf125-B69","doi-asserted-by":"publisher","first-page":"e2215418","DOI":"10.1001\/jamanetworkopen.2022.15418","article-title":"Trends in cannabis polysubstance use during early pregnancy among patients in a large health care system in Northern California","volume":"5","author":"Young-Wolff","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"3","key":"2025120419221994100_zxaf125-B70","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s10995-023-03592-w","article-title":"Systematic review: polysubstance prevalence estimates reported during pregnancy, US 2009-2020","volume":"27","author":"Tran","year":"2023","journal-title":"Matern Child Health J"},{"issue":"4","key":"2025120419221994100_zxaf125-B71","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s00737-022-01244-6","article-title":"Licit and illicit drug use across trimesters in pregnant women endorsing past year substances use: results from national survey on drug use and health (2009-2019)","volume":"25","author":"Peltier","year":"2022","journal-title":"Arch Womens Ment Health"},{"key":"2025120419221994100_zxaf125-B72","doi-asserted-by":"publisher","first-page":"109872","DOI":"10.1016\/j.drugalcdep.2023.109872","article-title":"Polysubstance use during pregnancy: the importance of screening, patient education, and integrating a harm reduction perspective","volume":"247","author":"Board","year":"2023","journal-title":"Drug Alcohol Dep"},{"issue":"6","key":"2025120419221994100_zxaf125-B73","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1097\/AOG.0000000000002619","article-title":"Recommendations from cannabis dispensaries about first-trimester cannabis use","volume":"131","author":"Dickson","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"10","key":"2025120419221994100_zxaf125-B74","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1001\/jamainternmed.2018.3581","article-title":"Association of nausea and vomiting in pregnancy with prenatal marijuana use","volume":"178","author":"Young-Wolff","year":"2018","journal-title":"JAMA Int Med"},{"issue":"1","key":"2025120419221994100_zxaf125-B75","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12245-020-00311-y","article-title":"Cannabinoid hyperemesis syndrome in the pregnant patient: clinical case and literature review","volume":"13","author":"Flament","year":"2020","journal-title":"Int J Emerg Med"},{"key":"2025120419221994100_zxaf125-B76","doi-asserted-by":"publisher","first-page":"99746062","DOI":"10.1155\/2018\/9746062","article-title":"Recurrent nausea and vomiting in a pregnant woman with chronic marijuana use","volume":"2018","author":"Kim","year":"2018","journal-title":"Case Rep Obstet Gynecol"},{"issue":"5","key":"2025120419221994100_zxaf125-B77","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/JCP.0000000000001579","article-title":"Treatment of cannabis hyperemesis syndrome using haloperidol in a pregnant patient: case report","volume":"42","author":"La Sala","year":"2022","journal-title":"J Clin Psychopharmcol"},{"issue":"2","key":"2025120419221994100_zxaf125-B78","doi-asserted-by":"publisher","first-page":"069","DOI":"10.23937\/2469-584X\/1510069","article-title":"Cannabinoid hyperemesis syndrome in pregnancy: a case report and treatment overview","volume":"5","author":"Nguyen","year":"2019","journal-title":"J Clin Gastroenterol Treat"},{"issue":"4","key":"2025120419221994100_zxaf125-B79","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1001\/jamainternmed.2019.7517","article-title":"Trends in cannabis use among older adults in the United States, 2015-2018","volume":"180","author":"Han","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"1","key":"2025120419221994100_zxaf125-B80","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/geriatrics5010002","article-title":"Cannabinoids in the older person: a literature review","volume":"5","author":"Beedham","year":"2020","journal-title":"Geriatrics"},{"issue":"4","key":"2025120419221994100_zxaf125-B81","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1208\/s12248-021-00616-7","article-title":"Cannabinoid interactions with cytochrome P450 drug metabolism: a full-spectrum characterization","volume":"23","author":"Doohan","year":"2021","journal-title":"AAPS J"},{"issue":"7-8","key":"2025120419221994100_zxaf125-B82","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1159\/000524746","article-title":"A case report on cannabinoid hyperemesis syndrome in palliative care: how good intentions can go wrong","volume":"45","author":"Senderovich","year":"2022","journal-title":"Oncol Res Treat"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxaf125\/63422420\/zxaf125.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxaf125\/63422420\/zxaf125.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxaf125\/63422420\/zxaf125.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:22:26Z","timestamp":1764894146000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/82\/24\/1340\/8155679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":82,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2025,6,3]]},"published-print":{"date-parts":[[2025,12,5]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxaf125","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12,15]]},"published":{"date-parts":[[2025,6,3]]}}}